Glucose starvation induces apoptosis in a model of acute t leukemia dependent on caspase-3 and apoptosis-inducing factor: A therapeutic strategy

Nutrition and Cancer

Volumn 65, Issue 1, 2013, Pages 99-109

  Mendivil Perez, Miguel ^a   Marlene Jimenez Del Rio, ^a   Velez Pardo, Carlos ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; APOPTOSIS INDUCING FACTOR; CASPASE 3; GLUCOSE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA FRAGMENTATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GLUCOSE STARVATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKEMIA CELL LINE; MEMBRANE DAMAGE; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; STARVATION; T CELL LEUKEMIA;

ANTIOXIDANTS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; CASPASE 3; CHROMATIN; DNA FRAGMENTATION; GLUCOSE; HUMANS; HYDROGEN PEROXIDE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; LEUKEMIA, T-CELL; MEMBRANE POTENTIAL, MITOCHONDRIAL; NF-KAPPA B; SUPEROXIDES; VITAMIN E;

EID: 84873702928     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.741751     Document Type: Article

References (57)

1. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100, 57-70, 2000.
2. Tennant DA, Durán RV, Boulahbel H, and Gottlieb E: Metabolic transformation in cancer. Carcinogenesis 30, 1269-1280, 2009.
3. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, et al.:Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16, 3-11, 2009.
4. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, et al.:Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19, 107-120, 2012.
5. Nowak D, Stewart D, and Koeffler HP, Differentiation therapy of leukaemia: 3 decades of development. Blood 113, 3655-3665, 2009.
6. Pieters R and Carroll WL: Biology and treatment of acute lymphoblastic leukaemia. Hematol Oncol Clin North Am 24, 1-18, 2010.
7. Chen W, Wang E, Lu Y, Gaal KK, and Huang Q: Therapy-related acute lymphoblastic leukaemia without 11q23 abnormality: report of six cases and a literature review. Am J Clin Pathol 133, 75-82, 2010.
8. Szotkowski T, Rohon P, Zapletalova L, Sicova K, and Hubacek J, et al.: Secondary acute myeloid leukaemia: a single center experience. Neoplasma 57, 170-178, 2010.
9. Annibaldi A and Widmann C: Glucose metabolism in cancer cells. Curr Opin Clin Nutr. Metab Care 13, 466-470, 2010.
10. 2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem J 418, 29-37, 2009.
11. Lee YJ, Galoforo SS, Berns CM, Tong WP, Kim HR, et al.: Glucose deprivation-induced cytotoxicity in drug resistant human breast carcinoma MCF-7/ADR cells: role of c-myc and bcl-2 in apoptotic cell death. J Cell Sci 110(Pt. 5), 681-686, 1997.
12. Lee YJ, Galoforo SS, Berns CM, Chen JC, Davis BH, et al.: Glucose deprivation-induced cytotoxicity and alterations in mitogen-activated protein kinase activation are mediated by oxidative stress in multidrugresistant human breast carcinoma cells. J Biol Chem 273, 5294-5299, 1998.
13. Blackburn RV, Spitz DR, Liu X, Galoforo SS, Sim JE, et al.: Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells. Free Radic Biol Med 26, 419-430, 1999.
14. Spitz DR, Sim JE, Ridnour LA, Galoforo SS, and Lee YJ: Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism? Ann N Y Acad Sci 899, 349-362, 2000.
15. Caro-Maldonado A, Tait SW, Ramiŕez-Peinado S, Ricci JE, Fabregat I, et al.: Glucose deprivation induces an atypical form of apoptosis mediated by caspase-8 in Bax-, Bak-deficient cells. Cell Death Differ 17, 1335-1344, 2010.
16. Aki T, Mizukami Y, Oka Y, Yamaguchi K, Uemura K, et al.: Phosphoinositide 3-kinase accelerates autophagic cell death during glucose deprivation in the cardiomyocyte-derived cell line H9c2. Oncogene 22, 8529-8535, 2003.
17. Marambio P, Toro B, Sanhueza C, Troncoso R, Parra V, et al.: Glucose deprivation causes oxidative stress and stimulates aggresome formation and autophagy in cultured cardiac myocytes. Biochim Biophys Acta 1802, 509-518, 2010.
18. El Mjiyad N, Caro-Maldonado A, Ramírez-Peinado S, and Muñoz-Pinedo C: Sugar-free approaches to cancer cell killing. Oncogene 30, 253-264, 2010.
19. Avila-Gomez IC, Velez-Pardo C, and Jimenez-Del-Rio M: Effects of insulin-like growth factor-1 on rotenone-induced apoptosis in lymphocyte cells. Basic & Clinical Pharmacology & Toxicology 106, 53-61, 2010.
20. 2), caspase-3, and nuclear factor kappa-B (NF-κB), p53, c-Jun transcription factor. Biochem Pharmacol 63, 677-688, 2002.
21. Liang ZQ, Li YL, Zhao XL, Han R, Wang XX, et al.: NF-kappa B contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53. Brain Res 1145, 190-203, 2007.
22. Son YO, Jang YS, Shi X, and Lee JC: Activation of JNK and c-Jun is involved in glucose oxidase-mediated cell death of human lymphoma cells. Mol Cells 28, 545-551, 2009.
23. Bonilla-Porras AR, Jimenez-Del-Rio M, and Velez-Pardo C: Vitamin K3 and vitamin C alone or in combination induced apoptosis in leukaemia cells by a similar oxidative stress signalling mechanism. Cancer Cell Int 11, 19, 2011.
24. Chaturvedi MM, Sung B, Yadav VR, Kannappan R, and Aggarwal BB: NF-κB addiction and its role in cancer: 'one size does not fit all'. Oncogene 30, 1615-1630, 2011.
25. Wang J and Yi J: Cancer cell killing via ROS. To increase or decrease, that is the question. Cancer Biology & Therapy 7, 1875-1884, 2008.
26. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, et al.: Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441-446, 1999.
27. Jänicke RU, Sprengart ML, Wati MR, and Porter AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273, 9357-9360, 1998.
28. Melinn M and McLaughlin H: Nitroblue tetrazolium reduction in lymphocytes. J Leukoc Biol 41, 325-329, 1987.
29. Leite M, Quinta-Costa M, Leite PS, and Guimaraes JE: Critical valuation of techniques to detect and measure cell death- study in a model of UV radiation of the leukaemic cell line HL60. Anal Cell Pathol 19, 139-151, 1999.
30. Kolenko VM, Uzzo RG, Dulin N, Hauzman E, Bukowski R, et al.: Mechanism of apoptosis induced by zinc deficiency in peripheral blood T lymphocytes. Apoptosis 6, 419-429, 2001.
31. Li J, Liu R, Lei Y, Wang K, Lau QC, et al. Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukaemia cells. Autophagy 6, 711-724, 2010.
32. Velez-Pardo C, Jimenez-Del-Rio M, Lores-Arnaiz S, and Bustamante J: Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain mitochondria upon paraquat exposure. Neurochem Res 35, 1323-1332, 2010.
33. 2 mediate glucose deprivation-induced stress in human cancer cells. J Biol Chem 280, 4254-4263, 2005.
34. Murphy MP: How mitochondria produce reactive oxygen species. Biochem J 417, 1-13, 2009.
35. Miramar MD, Costantini P, Ravagnan L, Saraiva LM, Haouzi D, et al.: NADH oxidase activity of mitochondrial apoptosis-inducing factor. J Biol Chem 276, 16391-16398, 2001.
36. Stridh H, Kimland M, Jones DP, Orrenius S, and Hampton MB:Cytochrome c release and caspase activation in hydrogen peroxide- and tributyltininduced apoptosis. FEBS Lett 429, 351-355, 1998.
37. Li GY and Osborne NN: Oxidative-induced apoptosis to an immortalized ganglion cell line is caspase independent but involves the activation of poly(ADP-ribose)polymerase and apoptosis inducing factor. Brain Res 1188, 35-43, 2008.
38. Son YO, Jang YS, Heo JS, Chung WT, Choi KC, et al.: Apoptosis-inducing factor plays a critical role in caspase-independent, pyknotic cell death in hydrogen peroxide exposed cells. Apoptosis 14, 796-808, 2009.
39. Barbouti A, Amorgianiotis C, Kolettas E, Kanavaros P, and Galaris D: Hydrogen peroxide inhibits caspase-dependent apoptosis by inactivating procaspase-9 in an iron-dependent manner. Free Radic Biol Med 43, 1377-1387, 2007.
40. Brigelius-Flohé R and Flohé L: Basic principles and emerging concepts in the redox control of transcription factors. Antioxid Redox Signal 15, 2335-2381, 2011.
41. Takada Y, Mukhopadhyay A, Kundu GC, Mahabeleshwar GH, Singh S, et al.: Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. J Biol Chem 278, 24233-24241, 2003.
42. Kamata H, Manabe T, Oka S, Kamata K, and Hirata H: Hydrogen peroxide activates Ikappa B kinases through phosphorylation of serine residues in the activation loops. FEBS Lett 519, 231-237, 2002.
43. Tobiume K, Saitoh M, and Ichijo H: Activation of apoptosis signal regulating kinase 1 by stress-induced activating phosphorylation of pre-formed oligomer. J Cell Physiol 191, 95-104, 2002.
44. Ichijo H, Nishida E, and Irie K: Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90-94, 1997.
45. Radhakrishnan SK and Kamalakaran S: Pro-apoptotic role of NF-kappa B: implications for cancer therapy. Biochim Biophys Acta 1766, 53-62, 2006.
46. Aleyasin H, Cregan SP, Iyirhiaro G, O'Hare MJ, Callaghan SM, et al.: Nuclear factor-(kappa)B modulates the p53 response in neurons exposed to DNA damage. J Neurosci 24, 2963-2973, 2004.
47. McNeill-Blue C, Wetmore BA, Sanchez JF, Freed WJ, and Merrick BA: Apoptosis mediated by p53 in rat neural AF5 cells following treatment with hydrogen peroxide and staurosporine. Brain Res 1112, 1-15, 2006.
48. Daugas E, Susin SA, Zamzami N, Ferri KF, Irinopoulou T, et al.: Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 14, 729-739, 2000.
49. Circu ML and Aw TY: Glutathione and apoptosis. Free Radic Res 42, 689-706, 2008.
50. Sakahira H, Enari M, and Nagata S: Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391, 96-99, 1998.
51. Mattes MJ: Apoptosis assays with lymphoma cell lines: problems and pitfalls. Br J Cancer 96, 928-936, 2007.
52. Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, et al.: Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ 16, 1093-1107, 2009.
53. Simons AL, Mattson DM, Dornfeld K, and Spitz DR: Glucose deprivationinduced metabolic oxidative stress and cancer therapy. J Cancer Res Ther 5(Suppl 1), S2-S6, 2009.
54. Lee C, Raffaghello L, Brandhorst S, Safdie FM, Bianchi G, et al.: Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med 4, 124-127, 2012.
55. Sandulache VC, Skinner HD, Wang Y, Chen Y, Dodge CT, Ow TJ, Bankson JA, Myers JN, Lai SY: Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation. Mol Cancer Ther 11, 1373-1380, 2012
56. Cardaci S, Desideri E, Ciriolo MR: Targeting aerobic glycolysis: 3- bromopyruvate as a promising anticancer drug. J Bioenerg Biomembr 44, 17-29, 2012.
57. Wang F, Ogasawara MA, and Huang P: Small mitochondria-targeting molecules as anti-cancer agents. Mol Aspects Med 31, 75-92, 2010.